These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 29562810

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration.
    Wanneh E, Luna G, Dufour R, Baass A.
    J Clin Lipidol; 2017; 11(1):55-60. PubMed ID: 28391911
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.
    Kent ST, Rosenson RS, Avery CL, Chen YI, Correa A, Cummings SR, Cupples LA, Cushman M, Evans DS, Gudnason V, Harris TB, Howard G, Irvin MR, Judd SE, Jukema JW, Lange L, Levitan EB, Li X, Liu Y, Post WS, Postmus I, Psaty BM, Rotter JI, Safford MM, Sitlani CM, Smith AV, Stewart JD, Trompet S, Sun F, Vasan RS, Woolley JM, Whitsel EA, Wiggins KL, Wilson JG, Muntner P.
    Circ Cardiovasc Genet; 2017 Aug; 10(4):e001632. PubMed ID: 28768753
    [Abstract] [Full Text] [Related]

  • 5. The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.
    Ooi TC, Krysa JA, Chaker S, Abujrad H, Mayne J, Henry K, Cousins M, Raymond A, Favreau C, Taljaard M, Chrétien M, Mbikay M, Proctor SD, Vine DF.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3452-3460. PubMed ID: 28673045
    [Abstract] [Full Text] [Related]

  • 6. Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.
    Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybjærg-Hansen A.
    BMJ; 2017 Apr 24; 357():j1648. PubMed ID: 28438747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).
    Mefford MT, Rosenson RS, Cushman M, Farkouh ME, McClure LA, Wadley VG, Irvin MR, Bittner V, Safford MM, Somaratne R, Monda KL, Muntner P, Levitan EB.
    Circulation; 2018 Mar 20; 137(12):1260-1269. PubMed ID: 29146683
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotype.
    Awan Z, Delvin EE, Levy E, Genest J, Davignon J, Seidah NG, Baass A.
    Can J Cardiol; 2013 Aug 20; 29(8):927-33. PubMed ID: 23743349
    [Abstract] [Full Text] [Related]

  • 11. R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction.
    Mostaza JM, Lahoz C, Salinero-Fort MA, de Dios O, Castillo E, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sabín C, López S, Cornejo V, de Burgos C, Sanchez V, Garcés C, investigators of the SPREDIA-2 Group.
    J Clin Lipidol; 2018 Aug 20; 12(4):1039-1046.e3. PubMed ID: 29773421
    [Abstract] [Full Text] [Related]

  • 12. Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levels.
    Lee CJ, Lee Y, Park S, Kang SM, Jang Y, Lee JH, Lee SH.
    PLoS One; 2017 Aug 20; 12(10):e0186446. PubMed ID: 29036232
    [Abstract] [Full Text] [Related]

  • 13. Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.
    Genga KR, Lo C, Cirstea MS, Leitao Filho FS, Walley KR, Russell JA, Linder A, Francis GA, Boyd JH.
    EBioMedicine; 2018 Dec 20; 38():257-264. PubMed ID: 30473376
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
    Slimani A, Jelassi A, Jguirim I, Najah M, Rebhi L, Omezzine A, Maatouk F, Hamda KB, Kacem M, Rabès JP, Abifadel M, Boileau C, Rouis M, Slimane MN, Varret M.
    Atherosclerosis; 2012 May 20; 222(1):158-66. PubMed ID: 22417841
    [Abstract] [Full Text] [Related]

  • 16. PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
    Mitchell KA, Moore JX, Rosenson RS, Irvin R, Guirgis FW, Shapiro N, Safford M, Wang HE.
    PLoS One; 2019 May 20; 14(2):e0210808. PubMed ID: 30726226
    [Abstract] [Full Text] [Related]

  • 17. The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis.
    Bonnefond A, Yengo L, Le May C, Fumeron F, Marre M, Balkau B, Charpentier G, Franc S, Froguel P, Cariou B, DESIR study group.
    Diabetologia; 2015 Sep 20; 58(9):2051-5. PubMed ID: 26049403
    [Abstract] [Full Text] [Related]

  • 18. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
    Kohli P, Ganz P, Ma Y, Scherzer R, Hur S, Weigel B, Grunfeld C, Deeks S, Wasserman S, Scott R, Hsue PY.
    J Am Heart Assoc; 2016 Apr 29; 5(5):. PubMed ID: 27130349
    [Abstract] [Full Text] [Related]

  • 19. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.
    Hopkins PN, Defesche J, Fouchier SW, Bruckert E, Luc G, Cariou B, Sjouke B, Leren TP, Harada-Shiba M, Mabuchi H, Rabès JP, Carrié A, van Heyningen C, Carreau V, Farnier M, Teoh YP, Bourbon M, Kawashiri MA, Nohara A, Soran H, Marais AD, Tada H, Abifadel M, Boileau C, Chanu B, Katsuda S, Kishimoto I, Lambert G, Makino H, Miyamoto Y, Pichelin M, Yagi K, Yamagishi M, Zair Y, Mellis S, Yancopoulos GD, Stahl N, Mendoza J, Du Y, Hamon S, Krempf M, Swergold GD.
    Circ Cardiovasc Genet; 2015 Dec 29; 8(6):823-31. PubMed ID: 26374825
    [Abstract] [Full Text] [Related]

  • 20. Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes/diabetes risk.
    Saavedra YGL, Dufour R, Baass A.
    J Clin Lipidol; 2015 Dec 29; 9(6):786-793.e1. PubMed ID: 26687699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.